Sanofi's New Insulin Shows 'Next-Generation' Potential in Study - Bloomberg

[INCIID News Feed]

Economic Times
<img alt="" height="1" width="1" />
Sanofi&#39;s New Insulin Shows &#39;Next-Generation&#39; Potential in Study
Bloomberg
Sanofi (SAN)&#39;s experimental diabetes drug U300 helped control glucose with fewer patients experiencing incidents of dangerously low blood-sugar levels at night than the company&#39;s Lantus in two clinical trials. The findings suggest U300 is potentially a ...
Sanofi&#39;s next-generation insulin shows edge over LantusReuters
Sanofi Reports Positive Phase 3 Results For Investigational New Insulin U300RTT News
Sanofi spotlights new PhIII diabetes data for son of LantusFierceBiotech
MENAFN.COM
all 14 news articles &raquo;


More...